Afjei, R.; Sadeghipour, N.; Kumar, S.U.; Pandrala, M.; Kumar, V.; Malhotra, S.V.; Massoud, T.F.; Paulmurugan, R.
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120.
https://doi.org/10.3390/cancers14246120
AMA Style
Afjei R, Sadeghipour N, Kumar SU, Pandrala M, Kumar V, Malhotra SV, Massoud TF, Paulmurugan R.
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers. 2022; 14(24):6120.
https://doi.org/10.3390/cancers14246120
Chicago/Turabian Style
Afjei, Rayhaneh, Negar Sadeghipour, Sukumar Uday Kumar, Mallesh Pandrala, Vineet Kumar, Sanjay V. Malhotra, Tarik F. Massoud, and Ramasamy Paulmurugan.
2022. "A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations" Cancers 14, no. 24: 6120.
https://doi.org/10.3390/cancers14246120
APA Style
Afjei, R., Sadeghipour, N., Kumar, S. U., Pandrala, M., Kumar, V., Malhotra, S. V., Massoud, T. F., & Paulmurugan, R.
(2022). A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers, 14(24), 6120.
https://doi.org/10.3390/cancers14246120